OptimizeRx
OPRX
OPRX
152 hedge funds and large institutions have $585M invested in OptimizeRx in 2022 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 65 increasing their positions, 49 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
37% less capital invested
Capital invested by funds: $930M → $585M (-$345M)
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
57% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 47
Holders
152
Holding in Top 10
3
Calls
$23.8M
Puts
$16.9M
Top Buyers
| 1 | +$8.19M | |
| 2 | +$7.11M | |
| 3 | +$6.17M | |
| 4 |
GIPM
G2 Investment Partners Management
New York
|
+$4.85M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$3.54M |
Top Sellers
| 1 | -$10.1M | |
| 2 | -$9.01M | |
| 3 | -$7.07M | |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$5.79M |
| 5 |
PCA
Prospect Capital Advisors
Sausalito,
California
|
-$2.86M |